Opko Health, Inc.

305 articles about Opko Health, Inc.

• Opko Health, Inc. to Present at UBS Warburg 2007 Global Life Sciences Conference

  9/18/2007

• Opko Health, Inc. Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD

  8/30/2007

• Opko Health, Inc. Announces Early Termination of Hart-Scott-Rodino Waiting Period for Proposed Purchase of Shares by Dr. Phillip Frost

  7/12/2007

• Opko Health, Inc. Initiates Phase 3 Trial of Bevasiranib for the Treatment of AMD

  7/11/2007

• Opko Health, Inc. to Acquire Diagnostic Imaging Firm

  6/1/2007